BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34066999)

  • 1. Modelling the Effect of MUC1 on Influenza Virus Infection Kinetics and Macrophage Dynamics.
    Li K; Cao P; McCaw JM
    Viruses; 2021 May; 13(5):. PubMed ID: 34066999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-Tethered Mucin 1 Is Stimulated by Interferon and Virus Infection in Multiple Cell Types and Inhibits Influenza A Virus Infection in Human Airway Epithelium.
    Iverson E; Griswold K; Song D; Gagliardi TB; Hamidzadeh K; Kesimer M; Sinha S; Perry M; Duncan GA; Scull MA
    mBio; 2022 Aug; 13(4):e0105522. PubMed ID: 35699372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell surface mucin MUC1 limits the severity of influenza A virus infection.
    McAuley JL; Corcilius L; Tan HX; Payne RJ; McGuckin MA; Brown LE
    Mucosal Immunol; 2017 Nov; 10(6):1581-1593. PubMed ID: 28327617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage Function.
    Marvin SA; Russier M; Huerta CT; Russell CJ; Schultz-Cherry S
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Mechanisms for Within-Host Influenza Virus Control Affect Model-Based Assessment and Prediction of Antiviral Treatment.
    Cao P; McCaw JM
    Viruses; 2017 Jul; 9(8):. PubMed ID: 28933757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMP4 regulates the innate immune response to influenza A virus infection.
    Yang S; Adaway M; Du J; Huang S; Sun J; Bidwell JP; Zhou B
    Mucosal Immunol; 2021 Jan; 14(1):209-218. PubMed ID: 32152414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.
    Cao P; Yan AW; Heffernan JM; Petrie S; Moss RG; Carolan LA; Guarnaccia TA; Kelso A; Barr IG; McVernon J; Laurie KL; McCaw JM
    PLoS Comput Biol; 2015 Aug; 11(8):e1004334. PubMed ID: 26284917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFITM3 and type I interferons are important for the control of influenza A virus replication in murine macrophages.
    Londrigan SL; Wakim LM; Smith J; Haverkate AJ; Brooks AG; Reading PC
    Virology; 2020 Jan; 540():17-22. PubMed ID: 31731106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of lncRNA-155 encoded by MIR155HG as a novel regulator of innate immunity against influenza A virus infection.
    Maarouf M; Chen B; Chen Y; Wang X; Rai KR; Zhao Z; Liu S; Li Y; Xiao M; Chen JL
    Cell Microbiol; 2019 Aug; 21(8):e13036. PubMed ID: 31045320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.
    Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust expression of p27Kip1 induced by viral infection is critical for antiviral innate immunity.
    Rai KR; Chen B; Zhao Z; Chen Y; Hu J; Liu S; Maarouf M; Li Y; Xiao M; Liao Y; Chen JL
    Cell Microbiol; 2020 Nov; 22(11):e13242. PubMed ID: 32596986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Within-Host Models of High and Low Pathogenic Influenza Virus Infections: The Role of Macrophages.
    Pawelek KA; Dor D; Salmeron C; Handel A
    PLoS One; 2016; 11(2):e0150568. PubMed ID: 26918620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAseq expression analysis of resistant and susceptible mice after influenza A virus infection identifies novel genes associated with virus replication and important for host resistance to infection.
    Wilk E; Pandey AK; Leist SR; Hatesuer B; Preusse M; Pommerenke C; Wang J; Schughart K
    BMC Genomics; 2015 Sep; 16(1):655. PubMed ID: 26329040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.
    LeMessurier KS; Lin Y; McCullers JA; Samarasinghe AE
    Antiviral Res; 2016 Sep; 133():208-17. PubMed ID: 27531368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling within-host dynamics of influenza virus infection including immune responses.
    Pawelek KA; Huynh GT; Quinlivan M; Cullinane A; Rong L; Perelson AS
    PLoS Comput Biol; 2012; 8(6):e1002588. PubMed ID: 22761567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1.
    Ramos I; Smith G; Ruf-Zamojski F; Martínez-Romero C; Fribourg M; Carbajal EA; Hartmann BM; Nair VD; Marjanovic N; Monteagudo PL; DeJesus VA; Mutetwa T; Zamojski M; Tan GS; Jayaprakash C; Zaslavsky E; Albrecht RA; Sealfon SC; García-Sastre A; Fernandez-Sesma A
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-mediated Suppression of Influenza-induced Pathology Requires CD11b/CD18 (MAC-1).
    Tak T; Rygiel TP; Karnam G; Bastian OW; Boon L; Viveen M; Coenjaerts FE; Meyaard L; Koenderman L; Pillay J
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):492-499. PubMed ID: 29141155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.
    Galani IE; Triantafyllia V; Eleminiadou EE; Koltsida O; Stavropoulos A; Manioudaki M; Thanos D; Doyle SE; Kotenko SV; Thanopoulou K; Andreakos E
    Immunity; 2017 May; 46(5):875-890.e6. PubMed ID: 28514692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.
    Kühn N; Bergmann S; Kösterke N; Lambertz RLO; Keppner A; van den Brand JMA; Pöhlmann S; Weiß S; Hummler E; Hatesuer B; Schughart K
    J Virol; 2016 May; 90(9):4298-4307. PubMed ID: 26889029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective and ATP-competitive kinesin KIF18A inhibitor suppresses the replication of influenza A virus.
    Cho YB; Hong S; Kang KW; Kang JH; Lee SM; Seo YJ
    J Cell Mol Med; 2020 May; 24(10):5463-5475. PubMed ID: 32253833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.